TXN2 (Thioredoxin 2) is a cytosolic redox protein in Saccharomyces cerevisiae yeast, critical for maintaining cellular redox balance and protein homeostasis. It belongs to the thioredoxin family, characterized by a conserved Cys-Gly-Pro-Cys active site that facilitates reversible disulfide bond reduction. TXN2 is distinct from its mitochondrial counterpart TRX3 and interacts with various enzymes and transcription factors to regulate oxidative stress responses and metabolic pathways . Recombinant TXN2 proteins are often produced in E. coli for research purposes but retain functional activity when studied in yeast systems .
Overexpression of TRX2 in wine yeast strains enhances biomass yield and fermentative capacity:
Strain | Biomass Yield (g/L) | Fermentative Capacity | Glutathione Level |
---|---|---|---|
Wild-type | 35.99 ± 3.34 | Standard | Lower GSH/GSSG ratio |
TRX2 Overexpressor | 54.78 ± 2.31 | 52% higher | Higher GSH/GSSG ratio |
This improvement correlates with reduced oxidative damage to lipids and proteins .
TXN2 overexpression upregulates antioxidant enzymes (e.g., SOD1, SOD2, catalase) and transcription factors (Yap1p, Msn2/Msn4), enhancing stress tolerance .
The trx1Δ trx2Δ mutant strain CY306 lacks endogenous thioredoxins, enabling in vivo identification of TRX2-specific targets via yeast two-hybrid (Y2H) assays. Key interactions include:
Deletion of TXN2 and TRX1 alters fatty acid biosynthesis and glycolytic flux:
Biotechnological Optimization: TXN2 overexpression improves yeast performance in biomass production and fermentation, making it valuable for industrial applications .
Redox Biology: CY306 strain reveals TRX2-specific interactions, advancing understanding of redox-regulated pathways .
Stress Adaptation: Mutations in HOG1 (e.g., in 2-phenylethanol-tolerant strains) highlight crosstalk between redox and osmotic stress responses .
This product consists of the Thioredoxin-2 protein derived from yeast and produced in E. coli. It is a single polypeptide chain that lacks glycosylation and has a molecular weight of 12.6kDa.
Each milligram of TRX2 protein is supplied in a buffer solution containing 20mM phosphate at a pH of 7.4.
To reconstitute the lyophilized TXN2, it is recommended to dissolve it in sterile water with a resistance of 18 megaohms per centimeter (18MΩ-cm H2O).
TXN2 remains stable at 4 degrees Celsius for up to 3 weeks. For long-term storage, it is recommended to store the desiccated protein below -18 degrees Celsius to ensure optimal preservation. Repeated freeze-thaw cycles should be avoided.
TXN2 activity is measured by monitoring the absorbance change at a wavelength of 650 nm and a temperature of 25°C. This assay determines the enzyme's ability to catalyze redox reactions. The specific activity of this product was determined to be 3 units per milligram of protein.
Thioredoxin-2, TRX2, TRX-2, TXN-2, TXN2.
TXN2 is a mitochondrial member of the thioredoxin family, a group of small multifunctional redox-active proteins. In eukaryotes including yeast, TXN2 is encoded by a nuclear gene but functions primarily in mitochondria. The protein is characterized by its redox-active site containing a conserved Trp-Cys-Gly-Pro-Cys motif, which plays a critical role in disulfide reduction .
In yeast cells, as in other eukaryotes, TXN2 regulates mitochondrial redox balance and protects against oxidant-induced apoptosis. The protein helps maintain mitochondrial membrane potential and contributes to cellular defense against reactive oxygen species (ROS) . Unlike its cytosolic counterpart TXN1, TXN2 contains a mitochondrial targeting sequence and lacks structural cysteines, facilitating its localization to the mitochondria where it performs specialized functions .
TXN2 expression in yeast, similar to other organisms, is highly responsive to metabolic demands and environmental stresses. The gene typically shows elevated expression in conditions of high metabolic activity or oxidative stress. When analyzing TXN2 expression in dynamic studies, researchers must carefully select appropriate reference genes for normalization, as traditional "housekeeping" genes often show variable expression under changing conditions .
For accurate quantification of TXN2 expression changes, real-time RT-qPCR with validated reference genes is essential. Studies have shown that using a pool of stable reference genes selected specifically for the experimental conditions yields significantly more reliable results than using common reference genes without validation .
Several complementary approaches are recommended for comprehensive analysis of TXN2 function in yeast:
While both yeast and human TXN2 serve similar functions in mitochondrial redox regulation, several important differences exist:
Feature | Yeast TXN2 | Human TXN2 |
---|---|---|
Molecular weight | ~12 kDa | 12 kDa |
Active site | Conserved Trp-Cys-Gly-Pro-Cys | Trp-Cys-Gly-Pro-Cys |
Localization | Mitochondrial | Mitochondrial |
Tissue expression | Ubiquitous, elevated in high metabolic activity | Highest in stomach, testis, ovary, liver, heart, neurons, adrenal gland |
Transcript variants | Multiple transcripts possible | Two main transcripts differing by ~330 bp in 3'-UTR |
Known interactors | Part of mitochondrial redox system | Regulates mitochondrial membrane potential |
Both proteins contain mitochondrial targeting sequences and lack structural cysteines compared to their cytosolic counterparts . Understanding these similarities and differences is essential when using yeast as a model system for human mitochondrial redox biology.
TXN2 participates in complex metabolic and regulatory networks within yeast cells. Recent studies using integrated metabolic-regulatory models reveal that TXN2 can form synthetic lethal interactions with other genes, suggesting functional redundancy or complementary roles in cellular survival pathways .
In one experimental system, TXN2 appeared in a synthetic lethal gene pair with TXN, indicating that yeast cells can tolerate the loss of either gene individually but not both simultaneously . This suggests overlapping functions between different thioredoxin family members despite their distinct subcellular localizations.
Integrated network analysis approaches combining metabolic models with regulatory networks provide a powerful framework for identifying such interactions. For example, models integrating Human1 metabolic network with regulatory databases such as TRRUST have successfully predicted synthetic lethal interactions involving TXN2 . Similar approaches could be applied to yeast-specific networks to map TXN2 interactions.
The essentiality of TXN2 appears to be context-dependent, similar to what has been observed in human cell lines. Using gMCS (genetic Minimal Cut Sets) analysis in integrated metabolic-regulatory networks, researchers have identified conditions under which TXN2 becomes essential .
In certain genetic backgrounds or metabolic states, TXN2 essentiality emerges due to:
Loss of redundant pathways: When genes with overlapping functions are downregulated or inactive, TXN2 becomes indispensable.
Metabolic rewiring: Changes in metabolic flux distribution can create increased dependence on mitochondrial redox systems.
Environmental stress: Under oxidative stress conditions, TXN2's role in protecting against ROS becomes critical for cell survival.
Regulatory relationships: The regulatory context influences TXN2 essentiality. For example, TXN2 has been found to be essential in cell lines where specific transcription factors like PPARD are not expressed .
Researchers investigating TXN2 essentiality should consider these contextual factors and employ systems biology approaches to identify the specific conditions under which TXN2 becomes indispensable.
Integrated metabolic-regulatory models provide a powerful framework for studying TXN2 function within the broader cellular context. These approaches have several advantages:
Identification of non-obvious interactions: Integrated models can reveal synthetic lethal interactions involving TXN2 that would not be apparent from studying metabolic or regulatory networks in isolation .
Context-specific predictions: By incorporating condition-specific data (e.g., transcriptomic profiles), these models can predict how TXN2 function varies across different cellular states.
Mechanistic insights: Rather than merely correlative relationships, integrated models provide mechanistic explanations for observed phenotypes by mapping the flow of cause and effect through the network.
Recent approaches have integrated metabolic networks with regulatory databases such as Omnipath, Dorothea, and TRRUST to identify essential genes and synthetic lethal interactions . Though primarily applied to human cells, these approaches are directly applicable to yeast systems.
For TXN2 specifically, integrated models could help explain why its essentiality is context-dependent and identify the specific metabolic and regulatory factors that determine its importance in different conditions.
Several complementary approaches can be employed to study TXN2 function in yeast:
CRISPR-Cas9 genome editing: Enables precise modification of the TXN2 gene, including complete deletion, point mutations in the active site, or tagging for protein localization studies.
Inducible expression systems: Placing TXN2 under the control of regulatable promoters allows for temporal control of expression, facilitating the study of immediate effects of TXN2 depletion.
In vivo evolutionary engineering: This approach, similar to that used in adaptation studies for other stress conditions, can reveal compensatory mechanisms when cells are forced to adapt to reduced TXN2 function .
Synthetic genetic array (SGA) analysis: Systematic creation of double mutants by crossing a TXN2 mutant with an array of other yeast deletion mutants can comprehensively map genetic interactions.
gMCS analysis in integrated networks: Computational prediction of genetic Minimal Cut Sets can identify synthetic lethal interactions involving TXN2, guiding experimental validation .
When designing these experiments, researchers should consider the potential confounding effects of metabolic state and growth conditions, as these factors influence the phenotypic consequences of TXN2 modification.
Disruption of TXN2 in yeast likely triggers complex transcriptional responses as cells attempt to maintain redox homeostasis. While specific data on yeast TXN2 transcriptomic responses is limited in the provided search results, general principles can be inferred:
Upregulation of alternative redox systems: Cells may compensate by increasing expression of cytosolic thioredoxins, glutathione systems, or other mitochondrial redox proteins.
Stress response activation: TXN2 disruption likely activates general stress response pathways, including those regulated by transcription factors like Msn2/4p that respond to various stresses, similar to the environmental stress response (ESR) observed in other yeast adaptation scenarios .
Metabolic reprogramming: Changes in mitochondrial redox state may trigger broader metabolic adaptations, affecting pathways such as respiration, fermentation, and amino acid metabolism.
When conducting transcriptomic studies of TXN2-disrupted yeast, it is crucial to select appropriate reference genes for RT-qPCR validation, as standard housekeeping genes may be affected by the resulting metabolic perturbations . Dynamic expression profiling at multiple time points post-disruption can provide insights into immediate versus adaptive responses.
Accurate quantification of TXN2 expression through RT-qPCR requires careful experimental design:
Reference gene selection: Traditional housekeeping genes often show variable expression under changing conditions. Use a candidate reference gene set specifically validated for your experimental conditions .
Dynamic expression profiling: When studying time-dependent responses, evaluate reference gene stability across all time points. The stability of reference genes may vary during dynamic responses .
Multiple reference genes: Use a pool of stable reference genes rather than a single reference gene. This approach has been shown to outperform common reference genes in determining dynamic transcriptional responses .
Primer design: Design primers that span exon-exon junctions when possible to avoid genomic DNA amplification, and validate primer efficiency and specificity.
Biological replicates: Include sufficient biological replicates (minimum 3) to account for natural variation in gene expression.
The use of properly validated reference genes is particularly important when studying genes like TXN2 that respond to metabolic and stress conditions, as these conditions often affect traditional housekeeping genes as well .
Contradictory results in TXN2 functional studies may arise from several sources:
Strain-specific effects: Different yeast strain backgrounds may show variable phenotypes in response to TXN2 manipulation due to genetic differences.
Growth conditions: Media composition, oxygen availability, and growth phase significantly impact mitochondrial function and may alter the consequences of TXN2 disruption.
Compensatory mechanisms: Yeast cells may activate alternative redox systems to compensate for TXN2 loss, potentially masking phenotypes in some conditions.
Technical variations: Differences in gene modification strategies, protein detection methods, or activity assays can lead to apparently contradictory results.
To resolve such contradictions, researchers should:
Standardize experimental conditions across studies
Use multiple complementary approaches to assess TXN2 function
Consider genetic background effects by testing in multiple strain backgrounds
Perform time-course experiments to distinguish immediate from adaptive responses
Employ systems biology approaches to place TXN2 function in broader cellular context
Validate key findings using orthogonal experimental techniques
Assessing TXN2 activity in yeast mitochondria presents technical challenges that can be addressed through several complementary approaches:
Mitochondrial isolation: Careful isolation of intact mitochondria is essential for accurate activity measurements. Differential centrifugation with density gradient purification helps obtain clean mitochondrial fractions.
Insulin reduction assay: The classic thioredoxin activity assay measures the rate of insulin disulfide reduction, which can be adapted for mitochondrial fractions.
Redox western blotting: This technique separates and quantifies the oxidized and reduced forms of TXN2 protein, providing direct evidence of its redox state in vivo.
Fluorescent redox sensors: Genetically encoded redox sensors targeted to mitochondria can provide real-time, in vivo measurements of compartment-specific redox changes in TXN2 mutants.
Targeted metabolomics: Analysis of mitochondrial metabolites affected by redox status, such as glutathione (GSH/GSSG ratio), provides indirect measures of TXN2 activity.
When interpreting activity data, it's important to consider that TXN2 functions within a complex redox network, and compensatory mechanisms may mask direct effects of TXN2 manipulation.
Integrated metabolic-regulatory models represent a significant advancement in predicting genetic interactions, including those involving TXN2. These models combine traditional metabolic networks with regulatory information to provide more accurate predictions :
Enhanced prediction accuracy: Integration of regulatory layers significantly increases the identification of true positive essential genes compared to metabolic models alone .
Context-specific predictions: These models can incorporate cell- or condition-specific data, enabling predictions tailored to particular experimental contexts.
Novel interaction discovery: Combined models have identified previously unknown synthetic lethal interactions, such as the TXN2 & TXN and TXN2 & PPARD pairs observed in certain cell lines .
Mechanistic insights: Beyond prediction, these models provide mechanistic explanations for synthetic lethality by mapping the regulatory and metabolic consequences of gene deletions.
The approach has been demonstrated using human metabolic models integrated with regulatory databases such as TRRUST, Dorothea, and Omnipath . When applied to yeast systems, similar integrative approaches could significantly enhance our understanding of TXN2 function within the broader cellular network.
For researchers studying TXN2, these models provide a valuable framework for generating hypotheses about genetic interactions that can be experimentally tested, potentially revealing unexpected functional relationships.
Research on TXN2 in yeast provides valuable insights into human disease mechanisms due to the high conservation of mitochondrial redox systems across eukaryotes:
Neurodegenerative diseases: Mitochondrial redox imbalance contributes to conditions like Parkinson's and Alzheimer's disease. Yeast models of TXN2 dysfunction can reveal fundamental mechanisms of mitochondrial stress responses relevant to neurodegeneration.
Cancer metabolism: TXN2 has been identified as essential in certain cancer cell lines, such as HELA and DLD1, where knockdown caused significant decreases in cell viability . Yeast studies can help elucidate the mechanistic basis for this dependence.
Aging processes: Mitochondrial redox systems play crucial roles in aging. Yeast, as a model for cellular aging, offers insights into how TXN2 contributes to lifespan regulation.
Metabolic disorders: TXN2's role in mitochondrial metabolism makes it relevant to understanding metabolic diseases. Yeast models can reveal how TXN2 dysfunction affects core metabolic processes.
The synthetic lethal interactions identified for TXN2 in integrated models suggest potential therapeutic targets . For example, the finding that TXN2 forms a synthetic lethal pair with PPARD in certain contexts points to potential vulnerabilities that could be exploited in disease treatment .
Evolutionary engineering, a process where microbial populations are subjected to selective pressure over many generations, provides valuable insights into adaptational responses involving TXN2:
Adaptive mutations: Long-term exposure to conditions that challenge mitochondrial redox homeostasis can reveal compensatory mutations that maintain fitness when TXN2 function is compromised.
Regulatory rewiring: Adaptive responses often involve changes in gene regulation, potentially revealing regulatory connections to TXN2 not evident in short-term experiments.
Metabolic reprogramming: Similar to adaptation seen in other stress responses, cells may undergo significant metabolic reprogramming to compensate for redox imbalance caused by TXN2 dysfunction .
Systems-level perspective: Evolutionary approaches provide a systems-level view of adaptation, capturing the complex interplay between genetic, regulatory, and metabolic responses.
This approach has been successfully applied to study adaptation to various stresses in yeast, including 2-phenylethanol resistance, where adapted strains showed characteristics of the environmental stress response (ESR) . Similar approaches could reveal how yeast adapts to chronic mitochondrial redox stress caused by TXN2 dysfunction.
Several emerging technologies are poised to transform TXN2 research in yeast systems:
Single-cell transcriptomics and proteomics: These technologies will reveal cell-to-cell variability in TXN2 expression and function, providing insights into the heterogeneity of redox responses.
Organelle-specific CRISPR screening: New approaches enabling mitochondria-specific genetic modifications will allow precise manipulation of TXN2 and related genes in their native compartment.
Multi-omics integration: Combining transcriptomic, proteomic, and metabolomic data with computational models will provide comprehensive views of how TXN2 influences cellular physiology.
Real-time redox imaging: Advanced fluorescent sensors with improved sensitivity and specificity will enable visualization of redox dynamics in live cells with subcellular resolution.
Expanded integrated models: More comprehensive integrated metabolic-regulatory models with multiple regulatory layers will improve prediction accuracy for TXN2 interactions .
AI-driven experimental design: Machine learning approaches will help optimize experimental conditions and predict outcomes, accelerating discovery in TXN2 research.
Researchers should consider how these emerging technologies can be incorporated into their experimental workflows to address previously intractable questions about TXN2 function.
Thioredoxins contain a conserved active site with the sequence Cys-Gly-Pro-Cys, which is essential for their redox activity. The primary function of thioredoxins is to catalyze the reduction of disulfide bonds in proteins, thereby maintaining proteins in their reduced and functional state. This redox activity is crucial for various cellular processes, including:
In yeast, Thioredoxin-2 (TRX2) is encoded by the YLR043C gene. It is a single, non-glycosylated polypeptide chain with a molecular weight of approximately 12.6 kDa . TRX2 is involved in maintaining the redox state of the cytoplasm and participates in various cellular functions essential for the viability of yeast cells.
Recombinant yeast thioredoxin-2 is typically produced in Escherichia coli (E. coli) as a soluble protein. The recombinant protein is purified to a high degree of purity, often greater than 95%, as determined by reverse-phase high-performance liquid chromatography (RP-HPLC) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) . The recombinant protein retains its enzymatic activity and can be used for various research applications.
Recombinant thioredoxin-2 has several applications in biotechnology and research: